Esperion Therapeutics
ESPR
ESPR
185 hedge funds and large institutions have $171M invested in Esperion Therapeutics in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 56 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
6.73% less ownership
Funds ownership: 63.97% → 57.24% (-6.7%)
38% less capital invested
Capital invested by funds: $277M → $171M (-$106M)
63% less call options, than puts
Call options by funds: $496K | Put options by funds: $1.36M
Holders
185
Holding in Top 10
1
Calls
$496K
Puts
$1.36M
Top Buyers
| 1 | +$10.8M | |
| 2 | +$5.23M | |
| 3 | +$1.6M | |
| 4 |
TSC
Two Seas Capital
Rye,
New York
|
+$1.01M |
| 5 |
Squarepoint
New York
|
+$775K |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$2.87M | |
| 3 | -$1.85M | |
| 4 |
Goldman Sachs
New York
|
-$1.77M |
| 5 |
Two Sigma Advisers
New York
|
-$1.57M |
